Media Center

FAH Statement | Prescription Drugs | FAH Policy Blog Team

FAH, AHA Briefing Drug Prices Draws Full House on Capitol Hill

The Federation of American Hospitals along with the American Hospital Association (AHA) and the American Society of Health-System Pharmacists (ASHP) held a briefing on Capitol Hill this week to present the findings from a recent joint study on drug pricing.

Presenting to a room packed with Congressional staffers and media members, the expert panel detailed the burden of skyrocketing drug prices on hospitals and outlined market-based solutions to ensure patients receive quality and affordable medicines.

The panel included Martin VanTrieste, president and CEO of Civica Rx; Jack Hoadley, research professor emeritus at Georgetown University’s Health Policy Institute; Molly Smith, AHA vice president for coverage and state issues; and Erik Rasmussen, AHA vice president of federal relations. 

Panelists used real-world examples to illustrate how relentless drug price increases and frequent shortages are eroding hospitals’ ability to care for patients. They also highlighted these main findings from the study, including:

  • Average total drug spending per hospital admission increased by 18.5% between FY2015 and FY2017.
  • Outpatient drug spending per admission increased by 28.7% while inpatient drug spending per admission increased by 9.6% between FY2015 and FY2017. This 9.6% increase was on top of the 38% increase in inpatient drug spending between FY2013 and FY2015 included in the previous report.
  • Very large percentage increases (over 80%) of unit price were seen across different classes of drugs, including those for anaesthetics, parenteral solutions, and chemotherapy.
  • Over 90% of surveyed hospitals reported having to identify alternative therapies to manage spending.
  • One in four hospitals had to cut staff to mitigate budget pressures.
  • Almost 80% of hospitals found it extremely challenging to obtain drugs experiencing shortages, while almost 80% also said that drug shortages resulted in increased spending on drugs to a moderate or large extent.

The full report can be found HERE. You can view a short video explaining the issue HERE and find an infographic HERE.